News

Filter

Current filters:

None

1 to 9 of 96304 results

FDA grants to stimulate drug and device development for rare diseases

01-10-2014

The US Food and Drug Administration yesterday announced it has awarded 15 grants totaling more than $19…

FinancialPharmaceuticalRare diseasesResearchUSA

Long-acting insulin is safer, more effective for patients with type 1 diabetes

01-10-2014

Long-acting insulin is safer and more effective than intermediate-acting insulin for patients with type…

DiabetesInsulin DetemirInsulin Glargine [rDNA origin] InjectionPharmaceuticalResearch

Sanofi and Regeneron's dupilumab meets all primary and secondary endpoints Phase IIa study

Sanofi and Regeneron's dupilumab meets all primary and secondary endpoints Phase IIa study

01-10-2014

French drug major Sanofi and US biotech company Regeneron's dupilumab has met all primary and secondary…

dupilumabFrancePharmaceuticalRegeneronResearchRespiratory and PulmonarySanofiUSA

ESMO 2014: Eisai’s Halaven could provide better quality of life for breast cancer patients

ESMO 2014: Eisai’s Halaven could provide better quality of life for breast cancer patients

01-10-2014

Data posters presented at this year’s European Society for Medical Oncology (ESMO) Congress in Madrid,…

EisaiHalavenJapanOncologyPharmaceuticalResearchSpain

ESMO 2014: AstraZeneca’s AZD9291 and Iressa

ESMO 2014: AstraZeneca’s AZD9291 and Iressa

01-10-2014

The annual congress of the European Society for Medical Oncology (ESMO) came to a close in Madrid, Spain,…

AstraZenecaAZD9291IressaOncologyPharmaceuticalResearchUK

Diplomat pharmacy receives expanded FDA approval for Xtandi in metastatic prostate cancer

Diplomat pharmacy receives expanded FDA approval for Xtandi in metastatic prostate cancer

01-10-2014

Independent specialty pharmacy Diplomat has received expanded approval for Xtandi (enzalutamide) from…

Astellas PharmaDiplomatMedivationOncologyPharmaceuticalRegulationUSAXtandi

1 to 9 of 96304 results

Back to top